View in EDS HTML Full Text PDF Full Text

Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.

Saved in:
Bibliographic Details
Title: Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
Authors: Ghosh N; Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, North Carolina, USA., Eyre TA; Churchill Hospital, Oxford University, Oxford, UK., Brown JR; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Lamanna N; Columbia University, New York, New York, USA., Manzoor BS; AbbVie Inc., North Chicago, Illinois, USA., Coombs CC; University of California Irvine, Irvine, California, USA., Tuncer HH; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ujjani C; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA., Leslie LA; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA., Roeker LE; CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Davids MS; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rhodes JM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Skarbnik AP; Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, North Carolina, USA., Sinai W; AbbVie Inc., North Chicago, Illinois, USA., Fleury I; Hôpital Maisonneuve-Rosemont, University of Montreal, Canada., Hill BT; Cleveland Clinic, Cleveland, Ohio, USA., Martinez-Calle N; Nottingham University Hospitals, NHS Trust, Nottingham, UK., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA., Jawaid D; AbbVie Inc., North Chicago, Illinois, USA., Emechebe N; AbbVie Inc., North Chicago, Illinois, USA., Pearson L; University of Massachusetts, Worcester, Massachusetts, USA., Lansigan F; Dartmouth Cancer Center, Lebanon, New Hampshire, USA., Choi Y; Tufts Medical Center, Boston, Massachusetts, USA., Jensen CE; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Fakhri B; Stanford Cancer Institute, Stanford University, Stanford, California, USA., Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Marx SE; AbbVie Inc., North Chicago, Illinois, USA., Schuster SJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Coyle M; Lowell General Hospital, Lowell, Massachusetts, USA., Pivneva I; Analysis Group Inc., Montreal, Quebec, Canada., Watson T; Analysis Group Inc., Montreal, Quebec, Canada., Guerin A; Analysis Group Inc., Montreal, Quebec, Canada., Shadman M; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA.
Source: American journal of hematology [Am J Hematol] 2025 Mar; Vol. 100 (3), pp. 511-515. Date of Electronic Publication: 2024 Dec 19.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39698781
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ghosh+N%22">Ghosh N</searchLink>; Levine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Eyre+TA%22">Eyre TA</searchLink>; Churchill Hospital, Oxford University, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Brown+JR%22">Brown JR</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lamanna+N%22">Lamanna N</searchLink>; Columbia University, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Manzoor+BS%22">Manzoor BS</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Coombs+CC%22">Coombs CC</searchLink>; University of California Irvine, Irvine, California, USA.<br /><searchLink fieldCode="AU" term="%22Tuncer+HH%22">Tuncer HH</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ujjani+C%22">Ujjani C</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA.<br /><searchLink fieldCode="AU" term="%22Leslie+LA%22">Leslie LA</searchLink>; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Roeker+LE%22">Roeker LE</searchLink>; CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Davids+MS%22">Davids MS</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rhodes+JM%22">Rhodes JM</searchLink>; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Skarbnik+AP%22">Skarbnik AP</searchLink>; Lymphoma and CLL Program, Novant Health Cancer Institute, Charlotte, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Sinai+W%22">Sinai W</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Fleury+I%22">Fleury I</searchLink>; Hôpital Maisonneuve-Rosemont, University of Montreal, Canada.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Cleveland Clinic, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Martinez-Calle+N%22">Martinez-Calle N</searchLink>; Nottingham University Hospitals, NHS Trust, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Barr+PM%22">Barr PM</searchLink>; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Jawaid+D%22">Jawaid D</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Emechebe+N%22">Emechebe N</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pearson+L%22">Pearson L</searchLink>; University of Massachusetts, Worcester, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lansigan+F%22">Lansigan F</searchLink>; Dartmouth Cancer Center, Lebanon, New Hampshire, USA.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Tufts Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Jensen+CE%22">Jensen CE</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Fakhri+B%22">Fakhri B</searchLink>; Stanford Cancer Institute, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Marx+SE%22">Marx SE</searchLink>; AbbVie Inc., North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Schuster+SJ%22">Schuster SJ</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Coyle+M%22">Coyle M</searchLink>; Lowell General Hospital, Lowell, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Pivneva+I%22">Pivneva I</searchLink>; Analysis Group Inc., Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Watson+T%22">Watson T</searchLink>; Analysis Group Inc., Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Guerin+A%22">Guerin A</searchLink>; Analysis Group Inc., Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Shadman+M%22">Shadman M</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, Washington State, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2025 Mar; Vol. 100 (3), pp. 511-515. <i>Date of Electronic Publication: </i>2024 Dec 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39698781
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.27563
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 511
    Titles:
      – TitleFull: Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ghosh N
      – PersonEntity:
          Name:
            NameFull: Eyre TA
      – PersonEntity:
          Name:
            NameFull: Brown JR
      – PersonEntity:
          Name:
            NameFull: Lamanna N
      – PersonEntity:
          Name:
            NameFull: Manzoor BS
      – PersonEntity:
          Name:
            NameFull: Coombs CC
      – PersonEntity:
          Name:
            NameFull: Tuncer HH
      – PersonEntity:
          Name:
            NameFull: Ujjani C
      – PersonEntity:
          Name:
            NameFull: Leslie LA
      – PersonEntity:
          Name:
            NameFull: Roeker LE
      – PersonEntity:
          Name:
            NameFull: Davids MS
      – PersonEntity:
          Name:
            NameFull: Rhodes JM
      – PersonEntity:
          Name:
            NameFull: Skarbnik AP
      – PersonEntity:
          Name:
            NameFull: Sinai W
      – PersonEntity:
          Name:
            NameFull: Fleury I
      – PersonEntity:
          Name:
            NameFull: Hill BT
      – PersonEntity:
          Name:
            NameFull: Martinez-Calle N
      – PersonEntity:
          Name:
            NameFull: Barr PM
      – PersonEntity:
          Name:
            NameFull: Jawaid D
      – PersonEntity:
          Name:
            NameFull: Emechebe N
      – PersonEntity:
          Name:
            NameFull: Pearson L
      – PersonEntity:
          Name:
            NameFull: Lansigan F
      – PersonEntity:
          Name:
            NameFull: Choi Y
      – PersonEntity:
          Name:
            NameFull: Jensen CE
      – PersonEntity:
          Name:
            NameFull: Fakhri B
      – PersonEntity:
          Name:
            NameFull: Stephens DM
      – PersonEntity:
          Name:
            NameFull: Marx SE
      – PersonEntity:
          Name:
            NameFull: Schuster SJ
      – PersonEntity:
          Name:
            NameFull: Coyle M
      – PersonEntity:
          Name:
            NameFull: Pivneva I
      – PersonEntity:
          Name:
            NameFull: Watson T
      – PersonEntity:
          Name:
            NameFull: Guerin A
      – PersonEntity:
          Name:
            NameFull: Shadman M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 100
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1